Answers are grounded in this paper and cite their sources.
In this patient-focused interview, EMJ spoke to Jean-Philippe Plançon, a patient with chronic inflammatory demyelinating polyneuropathy (CIDP) and the current President of the European Patients Organization for Dysimmune & Inflammatory Neuropathies (EPODIN). Plançon has lived with CIDP for 25 years and, in his role as patient advocate, acts as a voice for patients with CIDP and other immune-mediated peripheral neuropathies at the European level.
No takes yet. Share an insight, caveat, or question.
Helen Boreham (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: